Tuesday, October 19, 2021
News for Retirees


Value-effectiveness research for extensively used Medicare Half D medication are uncommon

Share this…FacebookPinterestTwitterLinkedin As extra emphasis is positioned on the worth of prescription medicines, a brand new examine discovered cost-effectiveness analyses…

By Staff , in Medicare , at June 22, 2021



As extra emphasis is positioned on the worth of prescription medicines, a brand new examine discovered cost-effectiveness analyses had been unavailable for most of the medicines that accounted for a big share of Medicare Half D spending in 2016. And greater than half of the analyses that had been carried out failed to fulfill minimal requirements.

Particularly, cost-effectiveness was not studied for 115 of the 250 medication for which Half D spending was biggest in 2016, the final yr for which full knowledge was obtainable when the examine started. These medicines accounted for 33% of the $146.1 billion in complete Half D spending that yr, based on the examine printed in JAMA Community Open.

Unlock this text by subscribing to STAT+ and luxuriate in your first 30 days free!

GET STARTED





Source link

Skip to content